Mandate

Vinge has advised Procuritas in connection with the sale of Ouriginal Group

Vinge has advised Procuritas, the private equity investor focused on investing in and growing Nordic mid-market companies, in connection with the sale of Ouriginal Group to Turnitin LLC, a global leader in academic integrity and education software.

Ouriginal, a company formed from the union of Urkund and PlagScan, has over three decades of experience in combining text-matching with writing-style analysis to promote academic integrity and prevent plagiarism in schools and universities.

Vinge’s team consisted of Jonas Johansson, Karl Klackenberg and Ellinor Wargenbrant (M&A), Mathilda Persson (IT), Tobias Kempas (IP), Sebastian Örndahl and Victoria Fredén (Competition) and Viktoria Owetz Leyva (VDR).

Related

Vinge advises OsteoCentric on the public offer for Integrum

OsteoCentric Oncology and Bone Anchored Prostheses, LLC, a subsidiary of OsteoCentric Technologies, Inc., has made a public offer for all shares in Integrum AB (publ). The offer values all shares in Integrum at approximately SEK 939 million.
July 23, 2025

Vinge advises Investor on its co-investment in the SEK 55 billion public offer for Fortnox led by EQT X

Vinge advises Investor AB (publ) (“Investor”) on its co-investment in the public offer for Fortnox AB (publ) (“Fortnox”) led by EQT X together with First Kraft AB (owned by Olof Hallrup), acting through Omega II AB (“Omega II”). Fortnox offers vital software infrastructure to small and medium-sized companies in Sweden with a track record of profitable growth.
July 22, 2025

Vinge advises Cantargia in connection with the sale of immunology program CAN10

Vinge advises Cantargia AB (publ) in connection with the sale of its early-clinical stage IL1RAP immunology program CAN10 to the Japanese healthcare company Otsuka Pharmaceutical.
July 21, 2025